Cart
sales@molnova.com
CPFX4158
CAS No. 1804962-84-2
CPFX4158( —— )
Catalog No. M23817 CAS No. 1804962-84-2
CPFX4158 is a mannose deriviative and an antibacterial agent that is potentially useful in transgenic humanized- CEACAM6 mouse.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 163 | In Stock |
|
| 10MG | 245 | In Stock |
|
| 25MG | 491 | In Stock |
|
| 50MG | 708 | In Stock |
|
| 100MG | 972 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCPFX4158
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPFX4158 is a mannose deriviative and an antibacterial agent that is potentially useful in transgenic humanized- CEACAM6 mouse.
-
DescriptionCPFX4158 is a mannose deriviative and an antibacterial agent that is potentially useful in transgenic humanized- CEACAM6 mouse.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1804962-84-2
-
Formula Weight985.98
-
Molecular FormulaC51H55NO19
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(N(CC1)CCC11c(cc(cc2)C#C[C@H]([C@H]([C@H]3OC(C)=O)OC(C)=O)O[C@H](COC(C)=O)[C@H]3OC(C)=O)c2-c(cc2)c1cc2C#C[C@H]([C@H]([C@H]1OC(C)=O)OC(C)=O)O[C@H](COC(C)=O)[C@H]1OC(C)=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
NITD-564
NITD-564 is a novel, direct inhibitor of the mycobacterial enoyl-reductase InhA with IC50 of 0.59 uM, exhibits MIC50 of 160 nM against Mtb.
-
LYS228
LYS228 is a novel potent monobactam that shows potent activity against carbapenem-resistant isolates of Enterobacteriaceae with MIC90 of 2 ug/ml.
-
Bedaquiline fumarate
Bedaquiline fumarate (R403323, TMC207 fumarate, R207910 fumarate) is a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections.
